Private Health Management („PHM“), a clinically sophisticated complex care management firm, announces the release of its whitepaper, „The Importance of Clinical Trials in Cancer Care.“ This report highlights the critical role of clinical trials in advancing cancer treatment, improving patient outcomes, and lowering costs for employers.
Clinical trials are crucial for testing the safety and efficacy of new medical treatments and interventions. However, access to these trials has often been hindered by the clinical and scientific complexity of identifying and prioritizing appropriate trials. Other challenges impacting enrollment include geographic location, socioeconomic status, and lack of awareness. According to recent estimates, just 7% of patients with cancer in the U.S. have participated in a clinical trial. PHM’s trial enrollment rate is 25%, demonstrating the potential for significantly higher participation in clinical trials when care management support is provided.
Entdecke mehr von LabNews
Melde dich für ein Abonnement an, um die neuesten Beiträge per E-Mail zu erhalten.
